惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

U
Unit 42
Google DeepMind News
Google DeepMind News
Stack Overflow Blog
Stack Overflow Blog
H
Help Net Security
MongoDB | Blog
MongoDB | Blog
I
InfoQ
N
Netflix TechBlog - Medium
T
Tailwind CSS Blog
量子位
博客园 - 叶小钗
月光博客
月光博客
IT之家
IT之家
G
Google Developers Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
小众软件
小众软件
S
SegmentFault 最新的问题
Engineering at Meta
Engineering at Meta
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
aimingoo的专栏
aimingoo的专栏
云风的 BLOG
云风的 BLOG
Vercel News
Vercel News
爱范儿
爱范儿
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
宝玉的分享
宝玉的分享

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript
2026-05-15 · via All Articles on Seeking Alpha

Biofrontera Inc. (BFRI) Q1 2026 Earnings Call May 14, 2026 11:00 AM EDT

Company Participants

Hermann Lubbert - CEO, President & Chairman
George Jones - Chief Commercial Officer
Eugene Leffler - Chief Financial Officer

Conference Call Participants

Ben Shamsian
Jonathan Aschoff - ROTH Capital Partners, LLC, Research Division
Bruce Jackson - The Benchmark Company, LLC, Research Division

Presentation

Operator

Good day, and welcome to Biofrontera Inc. First Quarter 2026 Financial Results and Business Update Conference Call. [Operator Instructions] Please note this event is being recorded.

I would like to turn the conference over to Ben Shamsian, Investor Relations. Please go ahead.

Ben Shamsian

Good morning, and welcome to Biofrontera Inc.'s First Quarter 2026 Financial Results and Business Update Conference Call. Please note that certain information discussed during today's call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act.

We caution listeners that Biofrontera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.

All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings, including the company's quarterly report on Form 10-Q for the quarter ended March 31, 2026, and the company's annual report on Form 10-K for the year ended December 31, 2025.

Also this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.

During today's call, there will be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors yet